
Home » Prescription Drugs 12 » NOVONORM Prandin
Repaglinide is used to treat type 2 diabetes (condition in which the body does not use insulin normally and therefore cannot control the amount of sugar in the blood). Repaglinide helps your body regulate the amount of glucose (sugar) in your blood. It decreases the amount of glucose by stimulating the pancreas to release insulin.Repaglinide comes as a tablet to take by mouth. The tablets are taken before meals any time from 30 minutes before a meal to just before the meal. If you skip a meal you need to skip the dose of repaglinide. If you add an extra meal you need to take an extra dose of repaglinide. Your doctor may gradually increase your dose depending on your response to repaglinide. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take repaglinide exactly as directed. Do not take more or less of it or take it more often than directed by the package label or prescribed by your doctor.
Buy NOVONORM Prandin and other Prescription Drugs 12 products online
at Medstore.
Buy Online at Medstore - Click Here!

About NOVONORM Prandin:
Product Type: Prescription Drugs 12
NOVONORM ( Prandin Generic Repaglinide )
NOVONORM (Prandin Generic Repaglinide)
Prandin Generic Repaglinide
0.5mg Tabs
Prandin Generic Repaglinide NOVONORM

View more
Prescription Drugs 12
Previous Product Next Product
Without A Prescription:
Education on antibiotic prescribing in Quebec worked. Guidelines for Quebec doctors on proper antibiotic use led to a decline in these prescriptions in the province, while prescribing rose in other provinces, a new study suggests.
The guidelines were published and disseminated to Quebec doctors and pharmacists in January 2005 due to worries about the overuse of antibiotics and partly as a response to an outbreak of Clostridium difficile infections.
Antibiotic consumption per capita was already 23.3 per cent higher in Canada generally than in Quebec in 2004, the study showed.
But in the year that followed publication of the guidelines, the number of outpatient antibiotic prescriptions in Quebec decreased 4.2 per cent, the study said, while increasing 6.5 per cent in other Canadian provinces. The trend persisted three years later.


|